An unverified report that China has formed a “Reopening Committee” has triggered a rally in Chinese stocks, but Beijing has denied any knowledge of the news.
Chinese regulators are encouraging (and enabling) companies to buy back their own stock to stabilize the country’s volatile markets. But will it work?
Beijing Tong Ren Tang is China’s leading traditional Chinese medicine (TCM) brand, with a history dating back to 1669. Tianjin Tong Ren Tang has a history dating back to 1852, but its IPO has been defeated due to a trademark dispute with its much more famous namesake.
Maybe the news doesn’t actually help you to invest? In this week’s look at the Chinese stock markets, Gerard DeBenedetto finds that the markets have already moved on from the breaking news.
When trying to find the bottom and eventual recovery, it’s best to align your strategy with those companies that will emerge to fit the policies articulated by Beijing.
Chinese stock markets are susceptible to wild oscillations but the associated risks don’t always bring returns, even to the savvy investor. Investing in the fixed income market is one way to help balance the volatility.
Tech stocks rallied today and stimulus is about to be unleashed, but wise investors should probably remain conservative, says Gerard DeBenedetto.
Making products to test and treat COVID-19 has made a fortune for some Chinese companies.
COVID lockdowns and war in Ukraine mean that tough economic times are coming. In China, that means a huge government stimulus. Gerard DeBenedetto explains how investors can take advantage.
Veteran tech investor and advisor Rui Ma answered our questions about the wild week that Chinese companies have had in markets on both sides of the Pacific.